MileBot Robotics

About MileBot Robotics

Founded in 2016, MileBot Robotics is a medical robotics company specializing in the development of exoskeleton robots for rehabilitation. The company was established by a team of PhDs with overseas experience in robotic rehabilitation technologies, including CEO Chen Gong, CTO Ye Jing, and COO Hu Feng. Chen Gong holds a PhD in Biomedical Engineering from the National University of Singapore, while Ye Jing earned a PhD in Biotechnology (Robotics) from Waseda University in Japan. Their collective expertise in robotics, human-computer interaction, and rehabilitation medicine forms the company's technical foundation.

MileBot Robotics operates in the medical rehabilitation market, serving clients such as hospitals, community health centers, and disability federations. The company's business model is centered on the sale of its robotic products and collaboration with institutions to enhance service quality and product performance. The firm has secured multiple rounds of funding, with notable investors including Lenovo Group and WEGO Group. Milestones include receiving angel funding in 2017, initiating clinical trials in 2019, and obtaining NMPA product registration in 2021 before starting a large-scale international expansion in 2024.

The company's product line focuses on lower limb rehabilitation, featuring a core technology of compliant actuators for safer human-robot interaction. Products include the BEAR series for adult lower limb rehabilitation, the RELAX series for pediatric patients, and the MAX Gait Assist Systems. These devices offer various training modes, from passive to active-assisted, and integrate with a Health Care Cloud Platform that uses IoT and big data for remote monitoring and assessment. The robots are designed to assist patients who have experienced strokes, spinal cord injuries, or brain injuries by providing targeted gait training. A key feature of some models is the inclusion of six powered joints, which allows for more natural and flexible movement during therapy.